Gabapentin
- Product NDC
- 51224-121
- 11-digit product format
- 512240121
- Labeler code
- 51224
- Product ID
- 51224-121_001831ce-47e9-4d0e-9aa5-d566575c2267
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- TAGI Pharma, Inc.
- Application
- ANDA207057
- Marketing category
- ANDA
- Marketing start
- 2019-05-01
- Marketing end
- 2026-12-31
- Substance
- GABAPENTIN
- Active strength
- 800 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 51224-121 | 51224-121-50 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207057-001 | GABAPENTIN | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | |
| A207057-002 | GABAPENTIN | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207057-001 | AB1 |
| A207057-002 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB1 | 2017-10-26 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB1 | 2017-10-26 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2017-10-26 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2017-10-26 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2017-10-26 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2017-10-26 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2017-10-26 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2017-10-26 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2017-10-26 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2017-10-26 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2017-10-26 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2017-10-26 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A207057-001 | GABAPENTIN | 600MG | TABLET / ORAL | AB | 2017-10-26 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A207057-002 | GABAPENTIN | 800MG | TABLET / ORAL | AB | 2017-10-26 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A207057-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207057-002 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207057-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207057-002 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207057-001 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A207057-002 | AB1 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207057-001 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207057-002 | AB1 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207057-001 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207057-002 | AB1 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207057-001 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207057-002 | AB1 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207057-001 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207057-002 | AB1 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207057-001 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207057-002 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207057-001 | AB1 | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207057-002 | AB1 | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207057-001 | AB1 | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A207057-002 | AB1 | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207057-001 | AB1 | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207057-002 | AB1 | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207057-001 | AB1 | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207057-002 | AB1 | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207057-001 | AB1 | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207057-002 | AB1 | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A207057-001 | AB1 | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A207057-002 | AB1 | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207057-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207057-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A207057-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A207057-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A207057-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A207057-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A207057-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A207057-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A207057-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A207057-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A207057-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A207057-002 | AB | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gabapentin
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GABAPENTIN | 800 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6CW7F3G59X | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 725878fa-1e2f-4fee-a9e1-a6e102c79625 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cdc2ae60-922e-452d-a42f-787fe4e2ed06 | Product name | 1 | 20250123 |
| 7059096a-4b9f-36c2-db50-bb5c723e6e9e | Product name | 2 | 20250114 |
| fa3f0129-3502-889f-f424-3a37727959e7 | Product name | 9 | 20181206 |
| 77d89e4c-f57f-326d-d7aa-787f8eebbd2b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51224-121-50 | Gabapentin | 100 in 1 BOTTLE | TABLET, COATED | 100 | 6 | |
| 51224-121-60 | Gabapentin | 500 in 1 BOTTLE | TABLET, COATED | 500 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51224-121-50 | EA - Each | 51224-121 | a6c15f78-be0d-43ac-a125-c27c2d31df2e | 1 | 2019-08-06 |
| 51224-121-60 | EA - Each | 51224-121 | 4b753741-b22f-467c-ad8d-f925088dcaa0 | 1 | 2019-08-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | TAGI Pharma, Inc. | 725878fa-1e2f-4fee-a9e1-a6e102c79625 | 2026-07-28 | Warnings, Adverse reactions | 207057 ANDA207057 51224-121 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d8604417-9d43-4d27-a7ce-d4120ff201f4 | 2026-06-11 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | b88b0cbc-c883-4d17-8f46-0e5bddc57835 | 2026-02-10 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 081fd1de-acaa-4685-a053-4959d77b17e9 | 2026-02-10 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | Precision Dose, Inc. | 021329d0-7d32-4fd8-81bf-a8b0d8b49e43 | 2025-12-04 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | b74a427c-9cc1-4b15-9ed2-cc891741fe67 | 2025-11-19 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | Mullan Pharmaceutical Inc. | 47a22de2-ec66-45be-8648-89ed3ab6e67e | 2025-10-28 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | Precision Dose, Inc. | 86c93d8b-6286-44e2-93dd-f1b10a5d83da | 2025-03-10 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 87b9171b-7d00-40fa-87ff-a717740efe8a | 2025-03-02 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 0ad67a07-59d0-4aaa-906b-befbbad8af31 | 2025-03-01 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | 07871ab8-254b-e3c2-e063-6294a90a29ab | 2025-02-03 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals, Inc. | 2c65253d-ca49-70eb-e063-6394a90a3cd2 | 2025-01-23 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | AvPAK | faa47fcd-2545-a946-e053-6294a90a05d2 | 2025-01-09 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | Advanced Rx of Tennessee, LLC | ec1a01fe-5531-21df-e053-2a95a90a0561 | 2024-12-31 | Warnings, Adverse reactions | 207057 ANDA207057 |
| Gabapentin | GABAPENTIN | Westminster Pharmaceuticals, LLC | 2eec52a1-9016-46dd-8b4c-8dab1d0aeece | 2024-12-23 | Warnings, Adverse reactions | 207057 ANDA207057 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310433 | gabapentin 600 MG Oral Tablet | PSN | 725878fa-1e2f-4fee-a9e1-a6e102c79625 | 6 |
| 310434 | gabapentin 800 MG Oral Tablet | PSN | 725878fa-1e2f-4fee-a9e1-a6e102c79625 | 6 |
| 310433 | gabapentin 600 MG Oral Tablet | SCD | 725878fa-1e2f-4fee-a9e1-a6e102c79625 | 6 |
| 310434 | gabapentin 800 MG Oral Tablet | SCD | 725878fa-1e2f-4fee-a9e1-a6e102c79625 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 51224-121-50 | 51224012150 | 100 TABLET, COATED in 1 BOTTLE (51224-121-50) | 2019-05-01 | 0000-00-00 | No | No | Current |
| 51224-121-60 | 51224012160 | 500 TABLET, COATED in 1 BOTTLE (51224-121-60) | 2019-05-01 | 2026-12-31 | No | No | Current |